{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:45:35Z","timestamp":1785926735632,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI129709-03S1"],"award-info":[{"award-number":["AI129709-03S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA260539-01"],"award-info":[{"award-number":["U01 CA260539-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CDC 200-2016-91773"],"award-info":[{"award-number":["CDC 200-2016-91773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["VA BX005507-01"],"award-info":[{"award-number":["VA BX005507-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"VHA BLRD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ebiom.2022.104066","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T17:46:16Z","timestamp":1653068776000},"page":"104066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-7888","authenticated-orcid":false,"given":"David H.","family":"Canaday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladayo A.","family":"Oyebanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Keresztesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore","family":"Carias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Htin","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"St. Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maegan L.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl M.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro B.","family":"Balazs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2022.104066_bib0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41577-022-00678-4","article-title":"Milder disease with Omicron: is it the virus or the pre-existing immunity?","volume":"22","author":"Sigal","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2022.104066_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104066_bib0003","unstructured":"Nursing Home Covid-19 Data Dashboard. 2022. https:\/\/www.cdc.gov\/nhsn\/covid19\/ltc-report-overview.html#anchor_1594393304."},{"issue":"5","key":"10.1016\/j.ebiom.2022.104066_bib0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMc2104849","article-title":"Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents","volume":"385","author":"White","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104066_bib0005","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/jgs.17176","article-title":"Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths","volume":"69","author":"Mor","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ebiom.2022.104066_bib0006","article-title":"Significant reduction in vaccine-induced antibody levels and neutralization activity among healthcare workers and nursing home residents 6 months following coronavirus disease 2019 BNT162b2 mRNA vaccination","author":"Canaday","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.ebiom.2022.104066_bib0007","doi-asserted-by":"crossref","first-page":"792","DOI":"10.15585\/mmwr.mm7021e3","article-title":"COVID-19 vaccine breakthrough infections reported to CDC - United States, January 1-April 30, 2021","volume":"70","year":"2021","journal-title":"MMWR Morbid Mortal Week Rept"},{"issue":"17","key":"10.1016\/j.ebiom.2022.104066_bib0008","doi-asserted-by":"crossref","first-page":"632","DOI":"10.15585\/mmwr.mm7017e1","article-title":"Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members - Chicago, Illinois, December 2020-March 2021","volume":"70","author":"Teran","year":"2021","journal-title":"MMWR Morbid Mortal Week Rept"},{"issue":"34","key":"10.1016\/j.ebiom.2022.104066_bib0009","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.15585\/mmwr.mm7034e3","volume":"70","author":"Nanduri","year":"2021","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104066_bib0010","doi-asserted-by":"crossref","first-page":"396","DOI":"10.15585\/mmwr.mm7011e3","article-title":"Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks - connecticut, December 2020-February 2021","volume":"70","author":"Britton","year":"2021","journal-title":"MMWR Morbid Morta Week Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104066_bib0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41423-021-00836-z","article-title":"Increased immune escape of the new SARS-CoV-2 variant of concern Omicron","volume":"19","author":"Hu","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"7898","key":"10.1016\/j.ebiom.2022.104066_bib0012","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.ebiom.2022.104066_bib0013","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.2021.19885","article-title":"Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in Adults Aged >\/=60 Years","volume":"326","author":"Eliakim-Raz","year":"2021","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ebiom.2022.104066_bib0014","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMc2113468","article-title":"SARS-CoV-2 Neutralization with BNT162b2 vaccine Dose 3","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104066_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2021.12.035","article-title":"Antibody responses to third-dose mRNA vaccines in nursing home and assisted living residents","author":"Zhang","year":"2022","journal-title":"J Am Med Directors Assoc"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104066_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104066_bib0017","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection","volume":"386","author":"Nemet","year":"2022","journal-title":"N Engl J Med"},{"issue":"10326","key":"10.1016\/j.ebiom.2022.104066_bib0018","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(22)00092-7","article-title":"Three-dose vaccination elicits neutralising antibodies against omicron","volume":"399","author":"Wu","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104066_bib0019","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/cid\/ciab447","article-title":"Reduced BNT162b2 messenger RNA vaccine response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-naive nursing home residents","volume":"73","author":"Canaday","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104066_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"7851","key":"10.1016\/j.ebiom.2022.104066_bib0021","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104066_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.09.011","article-title":"mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants","volume":"54","author":"Sokal","year":"2021","journal-title":"Immunity"},{"issue":"7889","key":"10.1016\/j.ebiom.2022.104066_bib0023","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-021-04060-7","article-title":"Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination","volume":"600","author":"Cho","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104066_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103748","article-title":"Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: impact of prior exposure and sex","volume":"74","author":"Tang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2022.104066_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01715-4","article-title":"Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern","author":"Wratil","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104066_bib0026","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1038\/s41467-021-24979-9","article-title":"Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses","volume":"12","author":"Ortega","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104066_bib0027","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3389\/fimmu.2019.02631","article-title":"Heterologous immunity: role in natural and vaccine-induced resistance to infections","volume":"10","author":"Agrawal","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104066_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109164","article-title":"Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs","volume":"35","author":"Stoddard","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104066_bib0029","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-021-23977-1","article-title":"Immunological imprinting of the antibody response in COVID-19 patients","volume":"12","author":"Aydillo","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104066_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta Variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104066_bib0031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.15585\/mmwr.mm7104e2","article-title":"COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of delta and omicron variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021","volume":"71","author":"Johnson","year":"2022","journal-title":"MMWR Morbid Mortal Weekly Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104066_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morbid.Mortal Weekly Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104066_bib0033","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMc2117385","article-title":"Effects of BNT162b2 Covid-19 vaccine booster in long-term care facilities in Israel","volume":"386","author":"Muhsen","year":"2022","journal-title":"N Engl J Med"},{"issue":"6576","key":"10.1016\/j.ebiom.2022.104066_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104066_bib0035","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104066_bib0036","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2022.01.002","volume":"40","author":"Uwamino","year":"2022","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.ebiom.2022.104066_bib0037","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104066_bib0038","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104066_bib0039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2021.7382","article-title":"Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine","volume":"182","author":"Patalon","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ebiom.2022.104066_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","author":"Barda","year":"2021","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ebiom.2022.104066_bib0041","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 VACCINE booster against Covid-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"N Engl J Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642200247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642200247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:17:07Z","timestamp":1762456627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642200247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":41,"alternative-id":["S235239642200247X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104066","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.07.21267179","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104066"}}